Andrology Department, Fundació Puigvert, Universitat Autònoma de Barcelona, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Centre of Excellence DeNothe, University of Florence, Florence, Italy.
Eur J Hum Genet. 2019 Oct;27(10):1578-1588. doi: 10.1038/s41431-019-0420-7. Epub 2019 May 3.
The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association between gr/gr deletion and TGCT, sperm parameters were unknown. Hence, it remains to be established whether this genetic defect truly represents a common genetic link between TGCT and impaired sperm production. Our aim was to explore the role of the following Y chromosome-linked factors in the predisposition to TGCT: (i) gr/gr deletion in subjects with known sperm parameters; (ii) other partial AZFc deletions and, for the first time, the role of partial AZFc duplications; (iii) DAZ gene dosage variation. 497 TGCT patients and 2030 controls from two Mediterranean populations with full semen/andrological characterization were analyzed through a series of molecular genetic techniques. Our most interesting finding concerns the gr/gr deletion and DAZ gene dosage variation (i.e., DAZ copy number is different from the reference sequence), both conferring TGCT susceptibility. In particular, the highest risk was observed when normozoospermic TGCT and normozoospermic controls were compared (OR = 3.7; 95% CI = 1.5-9.1; p = 0.006 for gr/gr deletion and OR = 1.8; 95% CI = 1.1-3.0; p = 0.013 for DAZ gene dosage alteration). We report in the largest European study population the predisposing effect of gr/gr deletion to TGCT as an independent risk factor from impaired spermatogenesis. Our finding implies regular tumour screening/follow-up in male family members of TGCT patients with gr/gr deletion and in infertile gr/gr deletion carriers.
生精障碍与睾丸生殖细胞瘤(TGCT)之间的关联促使人们对共同遗传因素展开研究。Y 染色体连锁的部分 AZFc 缺失易导致少精子症,并在 TGCT 患者中进行了研究,但结果存在争议。在最大规模的研究中,报道了 gr/gr 缺失与 TGCT 之间的关联,但精子参数未知。因此,是否这种遗传缺陷确实代表 TGCT 和精子生成受损之间的共同遗传联系仍有待确定。我们的目的是探讨以下 Y 染色体相关因素在 TGCT 易感性中的作用:(i)已知精子参数个体中的 gr/gr 缺失;(ii)其他部分 AZFc 缺失,以及首次研究部分 AZFc 重复;(iii)DAZ 基因剂量变化。通过一系列分子遗传技术,对来自两个地中海人群的 497 名 TGCT 患者和 2030 名对照者进行了分析,这些人群具有完整的精液/男科特征。我们最有趣的发现涉及 gr/gr 缺失和 DAZ 基因剂量变化(即 DAZ 拷贝数与参考序列不同),两者均导致 TGCT 易感性。特别是,在比较正常精子计数的 TGCT 和正常精子计数的对照组时,观察到最高的风险(gr/gr 缺失的比值比 [OR] = 3.7;95%置信区间 [CI] = 1.5-9.1;p = 0.006;DAZ 基因剂量改变的 OR = 1.8;95% CI = 1.1-3.0;p = 0.013)。我们在最大的欧洲研究人群中报告了 gr/gr 缺失对 TGCT 的易感性,作为精子发生障碍的独立危险因素。我们的发现意味着在 gr/gr 缺失的 TGCT 患者的男性家族成员和不育的 gr/gr 缺失携带者中,应定期进行肿瘤筛查/随访。